Your Opportunity
Access to medicines in low- and middle-income countries (LMICs) is a complex challenge and there is no ‘one size fits all solution. It requires deep understanding of the context, actors, economics and operational functions. The payer (global donors, national governments and private out-of-pocket) and procurer (supranational, national and sub-national) environment for LMIC markets is complex, heterogeneous across therapeutic categories, and is also rapidly-changing/evolving. Companies find it increasingly difficult to navigate this environment. Global market access teams have to learn new techniques and skills to understand this multi-stakeholder environment. This course brings together a faculty team with vast and rich experience in the theory and practice of access to medicines to help navigate/make decisions to be successful in LMIC markets.
While grounded in strong theory, the course will use case studies and practical examples as a pedagogical approach. The high profile of the international experts and the faculty involved in the course will ensure a highly interactive and rewarding learning environment.
21 Oct from 1pm CEST
Skype Chat with the Expert - Monica Otto, Program Director
Please write directly to Monica to book your place and arrange your time slot.
Skype Chat with the Expert - Viviana Mangiaterra, Program Coordinator
Please write directly to Viviana to book your place and arrange your time slot.
2 days face-to-face:
14-16 November 2019 (14 afternoon, 16 morning)
The program is designed for global market access managers interested in enhancing their understanding of the complexities in market access in LMICs and engaging with their peers.
"Access to medicines in low and middle income countries requires joint efforts and competencies by a wide range of stakeholders. The course will explore the conditions, tools and techniques that can make the difference. An opportunity to share in an international context and with a global perspective ideas, experiences, solutions...knowledge and passion for public value!"
"Creative, innovative approaches are needed in assuring essential medicines are manufactured, authorized, and distributed in low- and middle-income countries (LMICs) at affordable conditions. Global market access teams have to learn new techniques and to develop new skills to understand this complex multi-stakeholder environment. This course brings together an extraordinary faculty with vast experience in the theory and practice of access to medicines, a unique opportunity to learn how to navigate and be successful in these emerging markets."
Brenda Waning is the Chief of the Stop TB Partnership’s Global Drug Facility (GDF) – the world’s largest supplier of tuberculosis medicines and diagnostics for the public sector. Waning is a leading expert with more than 20 years of experience in promoting access to medicines in low-resource settings, with a focus on the intersection of pharmaceutical policy, market strategies, and access to medicines. She serves on several expert advisory groups across many different disease and technical areas.
Prashant Yadav is a Sr Lecturer at Harvard Medical School and Strategy Leader-Supply Chain at the Bill & Melinda Gates Foundation. Yadav is globally recognized scholar in healthcare supply chains in frontier markets. His work has also been featured in prominent print and broadcast media such Economist, Financial Times, Nature, and BBC.
The final deadline for enrollment is 25 October 2019. Enrollment requests are reviewed on a rolling basis, those received after the final deadline may not be accepted.
A 10% reduction on the program fee is offered to applications sent in by 15 September 2019.
All those who have taken part in the School's training programs become members, free of charge and with no expiration date, of the #MINE Community.
For further information and orientation: